MedPath

Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium

Phase 2
Conditions
Female infertility.
Female infertility of uterine origin
Registration Number
IRCT201512082604N2
Lead Sponsor
Vice Chancellor for research, Shahid Sadoughi University of Medical Sciences,Yazd, Iran.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
25
Inclusion Criteria

Infertile women who are candidate for frozen-thawed (ET); with at least 2 previous failed IVF cycle, thin endometrium (thickness less than 7 mm) despite conventional treatment in previous IVF cycles (vaginal estrogen; sildenafil; vitamin E; ...).
Exclusion criteria: Oocyte donation; Endometriosis; Polycystic Ovary Syndrome; Intrauterine lesion such as submucosal leiomyoma; history of endometriosis; and thyroid disorders.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 2-3 weeks after positive pregnancy test. Method of measurement: Fetal heartbeat after 2-3 weeks.;Chemical pregnancy. Timepoint: 2 weeks after emberyo transfer. Method of measurement: serum ßHCG.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath